CMO Selection: Making Sustainability a Top Priority

CMO Selection: Making Sustainability a Top Priority

As pharmaceutical businesses worldwide become more aware of the importance of meeting sustainability goals, it is inevitable that this will become a consideration when selecting a contract manufacturing organisation (CMO) or contract development and manufacturing organisation (CDMO). But it’s important to ensure that meeting sustainability goals when collaborating with external partners is genuine rather than just greenwashing.

That's why ahead of Pharma Contract Manufacturing 2024 we have collated exclusive insights on CMO Selection - Making Sustainability a Top Priority.

Access the infographic and dive into:

  • The Top 5 considerations for sustainable CMO selection
  • Key questions for the selection process
  • Changing the culture strategy
  • Examining your Scope 3 emissions
  • Real-world examples of setting measurable targets
  • Looking ahead: The big picture benefits

Please note: That all fields marked with an asterisk (*) are required.



Stay informed of events & get exclusive access to discounts

The information you provide will help IQPC deliver information to you about upcoming events and any discounts available. We may also email you industry reports and thought leadership pieces in your sector. We respect your right to privacy. Please read our privacy policy .

IQPC’s Pharma IQ is an online information service and global community for pharma professionals. If you Opt-In, Pharma IQ will send you regular pharma related content including in-depth industry reports, webinars and other exclusive information. Please read our privacy policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.